Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

This company has been marked as potentially delisted and may not be actively trading.

OptiNose (OPTN) News Today

OptiNose logo

OPTN Latest News

Optinose reports Q4 EPS (3c) vs ($1.33) last year
Optinose downgraded to Neutral from Buy at H.C. Wainwright
Optinose downgraded to Neutral from Overweight at Piper Sandler
Optinose downgraded to Hold from Buy at Lake Street
Lake Street Downgrades OptiNose (OPTN)
OptiNose trading resumes
Optinose price target adjusted for stock split at Lake Street
Lake Street Remains a Buy on Optinose (OPTN)
OptiNose trading halted, volatility trading pause
OptiNose trading halted, news pending
Optinose, Inc.: Optinose Announces 1-for-15 Reverse Stock Split
Optinose Sets 1-for-15 Reverse Stock Split
Optinose Announces 1-for-15 Reverse Stock Split
Optinose price target lowered to $1 from $3 at Piper Sandler
Optinose (OPTN) Gets a Buy from Piper Sandler
Optinose Shows Prescription Growth Amid Revenue Challenges
Optinose reports Q3 EPS 0c, consensus (5c)
Insights Ahead: OptiNose's Quarterly Earnings
Get OptiNose News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPTN and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OPTN Media Mentions By Week

OPTN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OPTN
News Sentiment

0.00

0.38

Average
Medical
News Sentiment

OPTN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OPTN Articles
This Week

0

0

OPTN Articles
Average Week

Get the Latest News and Ratings for OPTN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for OptiNose and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:OPTN) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners